Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention.

Yonsei Med J · 2022 · PMC8860942 · PMID 35184423

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

showed a trendp =0.061so close (0.05 < p ≤ 0.1)

Although prolonged DAPT showed a trend toward a decreased rate of MACCEs in patients without anemia (15.6% vs. 18.7%, p =0.061), the MACCE rate was similar between ≤12-m and >12-m DAPT in patients with anemia ( Fig. 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.